Quantcast Alnylam Pharmaceut Stock Quote | Stock Price for ALNY | Financial News | myMotherLode.com

Financial News

Motherlode Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Alnylam Pharmaceut (NQ: ALNY)
83.53 USD  +0.50 (+0.60%)
Official Closing Price  /  Updated: 5:32 PM EST, Feb 15, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 542,200
Open 83.34
Bid (Size) 75.00 (10)
Ask (Size) 86.45 (2)
Prev. Close 83.03
Today's Range 82.02 - 83.76
52wk Range 60.27 - 153.99
Shares Outstanding 100,522,411
Dividend Yield N/A
Performance
YTD
+14.80%
+14.80%
1 Month
+0.49%
+0.49%
3 Month
+16.86%
+16.86%
6 Month
-13.32%
-13.32%
1 Year
-30.87%
-30.87%
Top News
More News
Detailed Research: Economic Perspectives on DXC Technology, AMC Networks, SunCoke Energy Partners, Alnylam Pharmaceuticals, Amtech, and Diamond Hill Investment Group — What Drives Growth in Today's Co
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of DXC Technology Company.... Read More
from GlobeNewswire News Releases
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Recent Period Activity
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and full year ended December 31, 2018 and... Read More
from Business Wire News Releases
More News
Read More
Alnylam Announces Publication of Phase 1 Givosiran Data in The New England Journal of Medicine
from Business Wire News Releases
Alnylam to Webcast Presentations at Upcoming February Investor Conferences
from Business Wire News Releases
Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2018 Financial Results
from Business Wire News Releases
New Research Coverage Highlights Gentex, Tenneco, Mercury General, MGM Resorts International, ResMed, and Alnylam Pharmaceuticals — Consolidated Revenues, Company Growth, and Expectations for 2019
from GlobeNewswire News Releases
Alnylam Pharmaceuticals Prices Public Offering of Common Stock
from Business Wire News Releases
Alnylam Pharmaceuticals Announces Proposed Public Offering of Common Stock
from Business Wire News Releases
CAMP4 Therapeutics Announces Rare Disease Research Collaboration with Alnylam
from Business Wire News Releases
Is Moderna a Buy?
category EDIT , MRK , SGMO , and 6 more.
from Motley Fool
Alnylam Pharmaceuticals Is Launched and Ready for More
category ALNY , PFE , Market News
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Follow myMotherLode.com at these social networks Make Us Your Homepage Today Follow us on Facebook Follow us on Twitter Follow us on Youtube Follow us on LinkedIn Follow our RSS Feed
Yellow Pages

Popular Searches

Local Radio Stations
© Copyright 2000-2017 Clarke Broadcasting Corporation. All rights reserved.